Kazia Therapeutics Stock Forecast

Stock Price Forecast

The 2 analysts that cover Kazia Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $57.5, which forecasts a 808.37% increase in the stock price over the next year. The lowest target is $15 and the highest is $100.

Price Target: $57.5 (+808.37%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$15	$57.5	$100	$100
Change	+136.97%	+808.37%	+1479.8%	+1479.8%

Analyst Ratings

The average analyst rating for Kazia Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jan '25	Feb '25	Mar '25	Apr '25	May '25	Jun '25
Strong Buy	1	2	2	2	2	2
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	1	2	2	2	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jason McCarthy Maxim Group	Maxim Group	Strong Buy Maintains $15	Strong Buy	Maintains	$15	+136.97%	Jun 11, 2025
Jason McCarthy Maxim Group	Maxim Group	Strong Buy Initiates $15	Strong Buy	Initiates	$15	+136.97%	Feb 6, 2025
Sean Lee HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $100	Strong Buy	Reiterates	$100	+1,479.78%	Jul 12, 2024
Sean Lee HC Wainwright & Co.	HC Wainwright & Co.	Hold → Strong Buy Upgrades $100	Hold → Strong Buy	Upgrades	$100	+1,479.78%	Apr 11, 2023
Jason McCarthy Maxim Group	Maxim Group	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	Aug 2, 2022

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

from 2.48M

Revenue Next Year

n/a

EPS This Year

-26.52

from -50.78

EPS Next Year

-12.95

from -26.52

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Jun 30, 2020	Jun 30, 2021	Jun 30, 2022	Jun 30, 2023	Jun 30, 2024	Jun 30, 2025	Jun 30, 2026	Jun 30, 2027
Revenue	988.11K	15.18M	10.00K	1,000.00	2.48M	-	-	-
Revenue Growth	-31.38%	1,436.54%	-99.93%	-90.00%	248,000.00%	-	-	-
EPS	-85.35	-35.80	-94.42	-55.53	-50.78	-26.52	-12.95	-10.05
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	3	3	3

Financial currency is AUD. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	n/a	n/a	n/a
Avg	n/a	n/a	n/a
Low	n/a	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

EPS Forecast

EPS	2025	2026	2027
High	-27.30	-13.34	-10.34
Avg	-26.52	-12.95	-10.05
Low	-25.48	-12.45	-9.65

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.